Cargando…
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS
Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is a poorly understood disease which shows features resembling extranodal NK/T-cell lymphoma (ENKTL) and is currently not recognized as a distinct entity but categorized as a variant of primary T-cell lymphoma not otherwis...
Autores principales: | Wai, Cho Mar Myint, Chen, Shangying, Phyu, The, Fan, Shuangyi, Leong, Sai Mun, Zheng, Wenning, Low, Louis Ching Yi, Choo, Shoa-Nian, Lee, Chi-Kuen, Chung, Tae-Hoon, Ban, Kenneth Hon Kim, Ghosh, Soumita, Lie, Stefanus, Kato, Seiichi, Nakamura, Shigeo, Takahashi, Emiko, Ko, Young-Hyeh, Khoury, Joseph D., Chuang, Shih-Sung, Au-Yeung, Rex K.H., Tan, Soo-Yong, Lim, Soon-Thye, Ong, Choon-Kiat, Ho, Yong-Howe, Poon, Li Mei, de Mel, Sanjay, Jeyasekharan, Anand D., Chng, Wee-Joo, Otto, Franziska, Quintanilla-Martinez, Leticia, Zanardi, Federica, Iannelli, Fabio, Tripodo, Claudio, Pitt, Jason J., Ng, Siok-Bian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335103/ https://www.ncbi.nlm.nih.gov/pubmed/35021606 http://dx.doi.org/10.3324/haematol.2021.280003 |
Ejemplares similares
-
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
por: Rossi, Cédric, et al.
Publicado: (2022) -
PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion
por: Taylor, Joseph G., et al.
Publicado: (2022) -
Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies
por: Boot, Max V., et al.
Publicado: (2022) -
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes
por: Wagner, Charlotte B., et al.
Publicado: (2023) -
Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial
por: Ding, Kaiyang, et al.
Publicado: (2023)